injectable medications

Nearly 1 in 4 US adults with diabetes used injectable GLP-1 receptor agonists in 2024, reflecting rising adoption for glycemic control and obesity management with notable demographic disparities.

EPIK-O Trial Explores Alpelisib plus Olaparib Versus Chemotherapy in Platinum-Resistant High-Grade Serous Ovarian Cancer Without BRCA Mutation
FDA Approval of Trastuzumab Deruxtecan: Advancing Treatment for HR-Positive HER2-Low and Ultralow Metastatic Breast Cancer
Kidney Tubular Biomarkers as Predictors of Mortality and Heart Failure Readmission in Acute Heart Failure Patients
Timing Matters: Determining the Optimal Duration of Supervised Exercise for Meaningful Improvements in Peripheral Artery Disease
Serum Carboxymethyl-Lysine and Its Prospective Associations with Heart Failure and Atrial Fibrillation in Older Adults: Insights from the Cardiovascular Health Study

About us
Contact us
MedXY story
Privacy Policy
Subscribe Now!
账号

English
日本語
Tiếng Việt
中文

2型糖尿病 AI Alzheimer's disease artificial intelligence atrial fibrillation blood pressure breast cancer cardiovascular health cardiovascular risk clinical trial COVID-19 depression diabetes diet dinh dưỡng exercise GLP-1 health heart failure HFpEF Hypertension immunotherapy longevity mental health Mortality NAFLD nutrition obesity Pregnancy prevention public health randomized controlled trial randomized trial semaglutide sexual health Suy Tim sức khỏe tim mạch TAVI thử nghiệm lâm sàng type 2 diabetes weight loss wellness women's health 心力衰竭肥胖

Your health, we care

Scroll to Top